ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72 | +89.5% | 1,060 | +100.0% | 0.00% | – |
| Q2 2023 | $38 | -76.7% | 530 | -77.4% | 0.00% | – |
| Q1 2023 | $163 | +73.4% | 2,349 | +68.8% | 0.00% | – |
| Q4 2022 | $94 | -99.8% | 1,392 | +33.3% | 0.00% | – |
| Q3 2022 | $57,000 | +11.8% | 1,044 | +34.5% | 0.00% | – |
| Q2 2022 | $51,000 | +41.7% | 776 | +47.8% | 0.00% | – |
| Q1 2022 | $36,000 | +140.0% | 525 | +102.7% | 0.00% | – |
| Q4 2021 | $15,000 | -99.9% | 259 | -99.9% | 0.00% | -100.0% |
| Q3 2021 | $20,336,000 | +90.4% | 336,458 | +6.2% | 0.05% | +74.1% |
| Q3 2017 | $10,681,000 | +862.3% | 316,751 | +1716.6% | 0.03% | +575.0% |
| Q2 2015 | $1,110,000 | -6.6% | 17,436 | +0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,189,000 | -4.5% | 17,428 | -1.3% | 0.00% | 0.0% |
| Q4 2014 | $1,245,000 | +30.4% | 17,665 | +32.2% | 0.00% | +33.3% |
| Q3 2014 | $955,000 | +59.7% | 13,365 | +65.7% | 0.00% | +50.0% |
| Q2 2014 | $598,000 | +14.8% | 8,065 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $521,000 | – | 8,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |